Regulatory action and moderate decrease in methylphenidate use among ADHD diagnosed patients aged five and under in Korea
- 1 July 2015
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 72 (2) , 244-248
Abstract
No abstract availableKeywords
Funding Information
- MFDS (14172-174)
- National Health Insurance Service
This publication has 15 references indexed in Scilit:
- Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepinesCanadian Medical Association Journal, 2012
- Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in JapanInternational Journal of Clinical Pharmacy, 2012
- Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010Pediatrics, 2012
- ADHD Drugs and Serious Cardiovascular Events in Children and Young AdultsNew England Journal of Medicine, 2011
- Sudden Death and Use of Stimulant Medications in YouthsAmerican Journal of Psychiatry, 2009
- ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric PatientsAmerican Journal of Health-System Pharmacy, 2005
- Symptomatic Improvement in Children With ADHD Treated With Long-Term Methylphenidate and Multimodal Psychosocial TreatmentJournal of the American Academy of Child & Adolescent Psychiatry, 2004
- National Trends in the Use of Psychotropic Medications by ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Impact of a Web-Based Clinical Information System on Cisapride Drug Interactions and Patient SafetyArchives of internal medicine (1960), 1999
- Safety Issues in the Use of Methylphenidate An American PerspectiveDrug Safety, 1997